Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs WY✓SelectedUSD · WYGSK vs WY performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs WY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
WY return
-8.8%
Excess return
+105.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioWYExcessAlpha
1D-0.1%+0.3%-0.4%-0.2%
7D-5.3%-5.9%+0.5%-4.0%
30D-3.7%+3.2%-6.9%-4.4%
3M-7.3%-19.7%+12.4%-2.8%
6M-4.2%-14.2%+10.0%-1.2%
YTD+0.9%-15.1%+16.0%+4.1%
1Y+7.3%-5.0%+12.3%+8.0%
3Y+52.7%-33.2%+85.9%+64.2%
5Y+40.1%-37.1%+77.2%+50.3%
All+97.1%-8.8%+105.9%+80.9%

Cumulative growth

Daily Returns

Daily percentage return beside WY.

Daily Out/Under-Performance

Portfolio return minus WY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × WY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded WY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling